You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
27 November 2019
AFT Pharmaceuticals is set to launch Maxigesic/Combogesic in Canada through a licensing deal with local firm BioSyent Pharma. The New Zealand company has also recently agreed deals for the combination pain reliever in Germany, Pakistan and Vietnam.
14 October 2019
AFT Pharmaceuticals is joining forces with fellow New Zealand company SETEK to develop medicinal cannabis products.
21 June 2019
New Zealand's AFT Pharmaceuticals has announced its first outlicensing deal for the Maxigesic combination painkiller in South America.
6 December 2018
News in brief from The Nature's Bounty Co, Pfizer Consumer Healthcare, AFT Pharmaceuticals and Celesio UK.
2 October 2018
New Zealand's AFT Pharmaceuticals has outlicensed its Maxigesic combination painkiller to three separate companies in Russia, Hong Kong and Taiwan.